We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Beyfortus
Australian Public Assessment Report
Device/Product Name
Beyfortus
Active ingredients
Nirsevimab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-04428-1-2
Submission Type
New biological entity
Decision
Approved